Richard C. Centore

1.6k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

Richard C. Centore is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Richard C. Centore has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Hematology. Recurrent topics in Richard C. Centore's work include DNA Repair Mechanisms (8 papers), Protein Degradation and Inhibitors (5 papers) and Bacterial Genetics and Biotechnology (4 papers). Richard C. Centore is often cited by papers focused on DNA Repair Mechanisms (8 papers), Protein Degradation and Inhibitors (5 papers) and Bacterial Genetics and Biotechnology (4 papers). Richard C. Centore collaborates with scholars based in United States and United Kingdom. Richard C. Centore's co-authors include Lee Zou, Steven J. Sandler, Rachel Litman Flynn, Gabriel J. Sandoval, Luis M. Soares, Cigall Kadoch, Ho Man Chan, Jan Karlseder, Sandy Chang and Rekha Rai and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Richard C. Centore

14 papers receiving 1.1k citations

Hit Papers

Mammalian SWI/SNF Chromatin Remodeling Complexes: Emergin... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard C. Centore United States 12 1.0k 200 164 159 120 17 1.1k
Lam Leduy Canada 20 699 0.7× 154 0.8× 209 1.3× 64 0.4× 233 1.9× 29 1.0k
Jiang-Cheng Shen United States 8 798 0.8× 133 0.7× 133 0.8× 88 0.6× 370 3.1× 8 1.0k
Lin Ye United States 6 804 0.8× 297 1.5× 206 1.3× 39 0.2× 74 0.6× 8 912
Joel E. Straughen United States 6 1.2k 1.1× 238 1.2× 215 1.3× 75 0.5× 322 2.7× 9 1.4k
Bonnie Burgess-Beusse United States 8 1.0k 1.0× 368 1.8× 226 1.4× 54 0.3× 91 0.8× 8 1.3k
A. Lehmann United Kingdom 11 907 0.9× 114 0.6× 196 1.2× 40 0.3× 222 1.9× 19 1.0k
Nidhi Nair Denmark 7 796 0.8× 104 0.5× 258 1.6× 108 0.7× 89 0.7× 8 898
Assaf C. Bester Israel 13 1.2k 1.1× 248 1.2× 278 1.7× 43 0.3× 363 3.0× 16 1.3k
Sabine Schreek Germany 9 459 0.4× 180 0.9× 239 1.5× 75 0.5× 177 1.5× 14 730
Grzegorz Sarek United Kingdom 17 705 0.7× 66 0.3× 515 3.1× 347 2.2× 102 0.8× 19 1.2k

Countries citing papers authored by Richard C. Centore

Since Specialization
Citations

This map shows the geographic impact of Richard C. Centore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Centore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Centore more than expected).

Fields of papers citing papers by Richard C. Centore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Centore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Centore. The network helps show where Richard C. Centore may publish in the future.

Co-authorship network of co-authors of Richard C. Centore

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Centore. A scholar is included among the top collaborators of Richard C. Centore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Centore. Richard C. Centore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sandoval, Gabriel J., Richard C. Centore, GiNell Elliott, et al.. (2023). Abstract A056: Treatment with dual BRG1/BRM (SMARCA4/2) inhibitor FHD-286 ablates tumor-associated androgen response elements (AREs) in prostate cancer. Molecular Cancer Therapeutics. 22(12_Supplement). A056–A056.
2.
Wilson, Molly M., Ammar Adam, Oliver R. Mikse, et al.. (2023). Abstract A064: Establishing the cellular and molecular impacts of the dual BRM/BRG1 inhibitor FHD-286 on pre-clinical models of non-small cell lung cancer (NSCLC). Molecular Cancer Therapeutics. 22(12_Supplement). A064–A064.
3.
Ichikawa, Kana, Ammar Adam, Hsin‐Jung Wu, et al.. (2022). 888 Synergistic efficacy of the BRM/BRG1 ATPase inhibitor, FHD-286, and anti-PD-1 antibody in mouse syngeneic tumor models. Regular and Young Investigator Award Abstracts. A925–A925. 2 indexed citations
4.
Centore, Richard C., Gabriel J. Sandoval, Luis M. Soares, Cigall Kadoch, & Ho Man Chan. (2020). Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies. Trends in Genetics. 36(12). 936–950. 227 indexed citations breakdown →
5.
Conery, Andrew R., Richard C. Centore, Archana Bommi‐Reddy, et al.. (2016). Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response. Cancer Research. 76(6). 1313–1319. 23 indexed citations
6.
Conery, Andrew R., Richard C. Centore, Adrianne Neiss, et al.. (2016). Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. eLife. 5. 84 indexed citations
7.
Keller, Patricia J., Andrew R. Conery, Richard C. Centore, et al.. (2016). Abstract 4749: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. Cancer Research. 76(14_Supplement). 4749–4749.
8.
Centore, Richard C., et al.. (2012). Spartan/C1orf124, a Reader of PCNA Ubiquitylation and a Regulator of UV-Induced DNA Damage Response. Molecular Cell. 46(5). 625–635. 114 indexed citations
9.
Havens, Courtney G., Estrella Guarino, Richard C. Centore, et al.. (2012). Direct Role for Proliferating Cell Nuclear Antigen in Substrate Recognition by the E3 Ubiquitin Ligase CRL4Cdt2. Journal of Biological Chemistry. 287(14). 11410–11421. 40 indexed citations
10.
Flynn, Rachel Litman, Richard C. Centore, Roderick J. O’Sullivan, et al.. (2011). TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature. 471(7339). 532–536. 264 indexed citations
11.
Centore, Richard C., Courtney G. Havens, Amity L. Manning, et al.. (2010). CRL4Cdt2-Mediated Destruction of the Histone Methyltransferase Set8 Prevents Premature Chromatin Compaction in S Phase. Molecular Cell. 40(1). 22–33. 185 indexed citations
12.
Long, Jarukit E., Nicholas Renzette, Richard C. Centore, & Steven J. Sandler. (2008). Differential Requirements of Two recA Mutants for Constitutive SOS Expression in Escherichia coli K-12. PLoS ONE. 3(12). e4100–e4100. 17 indexed citations
13.
Centore, Richard C., et al.. (2008). UvrD303, a Hyperhelicase Mutant That Antagonizes RecA-Dependent SOS Expression by a Mechanism That Depends on Its C Terminus. Journal of Bacteriology. 191(5). 1429–1438. 21 indexed citations
14.
Centore, Richard C., Roxane Lestini, & Steven J. Sandler. (2007). XthA (Exonuclease III) regulates loading of RecA onto DNA substrates in log phase Escherichia coli cells. Molecular Microbiology. 67(1). 88–101. 29 indexed citations
15.
Centore, Richard C. & Steven J. Sandler. (2007). UvrD Limits the Number and Intensities of RecA-Green Fluorescent Protein Structures in Escherichia coli K-12. Journal of Bacteriology. 189(7). 2915–2920. 35 indexed citations
16.
Renzette, Nicholas, Nathan Gumlaw, Jared T. Nordman, et al.. (2005). Localization of RecA in Escherichia coli K‐12 using RecA–GFP. Molecular Microbiology. 57(4). 1074–1085. 95 indexed citations
17.
Centore, Richard C., et al.. (1995). Pharmacokinetic profile of raxofelast, A novel antioxidant agent chemically related to alpha-Tocopherol. Pharmacological Research. 31. 38–38. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026